Endothelial soluble guanylate cyclase enzyme inhibitors as a novel target for the treatment of sepsis-related hypotension
Crossref DOI link: https://doi.org/10.1038/s41598-025-20913-x
Published Online: 2025-10-22
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Suleiman, Yousif Ali Ahmed
Khalil, Abuzor Mohamed Mohyeldin
Almofti, Yassir A.
Text and Data Mining valid from 2025-10-22
Version of Record valid from 2025-10-22
Article History
Received: 11 January 2025
Accepted: 17 September 2025
First Online: 22 October 2025
Declarations
:
: The authors declare no competing interests.